Joseph Eid

1.1k total citations
16 papers, 691 citations indexed

About

Joseph Eid is a scholar working on Hematology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Joseph Eid has authored 16 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 6 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Joseph Eid's work include Histone Deacetylase Inhibitors Research (4 papers), Multiple Myeloma Research and Treatments (3 papers) and Iron Metabolism and Disorders (3 papers). Joseph Eid is often cited by papers focused on Histone Deacetylase Inhibitors Research (4 papers), Multiple Myeloma Research and Treatments (3 papers) and Iron Metabolism and Disorders (3 papers). Joseph Eid collaborates with scholars based in United States, Canada and Australia. Joseph Eid's co-authors include Joseph Aisner, Jennifer Houp, Sabine Eckhardt, Kenneth C. Anderson, Thorsten Graef, Hartmut Goldschmidt, Stephen Leong, Meletios Α. Dimopoulos, Gérard Greig and Amita Patnaik and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Joseph Eid

16 papers receiving 679 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Eid United States 10 446 304 199 119 78 16 691
Anne-Marie O’Farrell United States 6 360 0.8× 332 1.1× 214 1.1× 113 0.9× 45 0.6× 6 758
Steven M. Bair United States 9 415 0.9× 103 0.3× 171 0.9× 49 0.4× 76 1.0× 22 671
Claire Bléchet France 12 194 0.4× 99 0.3× 140 0.7× 56 0.5× 44 0.6× 27 470
I Marschitz Austria 12 280 0.6× 101 0.3× 146 0.7× 38 0.3× 77 1.0× 17 616
Carmen Julia Tartari Italy 11 227 0.5× 129 0.4× 108 0.5× 97 0.8× 42 0.5× 25 421
Ayako Mitsuma Japan 13 189 0.4× 63 0.2× 294 1.5× 122 1.0× 59 0.8× 43 532
Petra Goldin-Lang Germany 14 251 0.6× 161 0.5× 123 0.6× 47 0.4× 17 0.2× 23 577
Paraskevi Kotsi Greece 10 428 1.0× 89 0.3× 141 0.7× 27 0.2× 63 0.8× 19 725
Ram Chillar United States 12 171 0.4× 231 0.8× 174 0.9× 58 0.5× 23 0.3× 17 589
Emma Guagnellini Italy 12 186 0.4× 114 0.4× 236 1.2× 93 0.8× 49 0.6× 21 693

Countries citing papers authored by Joseph Eid

Since Specialization
Citations

This map shows the geographic impact of Joseph Eid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Eid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Eid more than expected).

Fields of papers citing papers by Joseph Eid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Eid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Eid. The network helps show where Joseph Eid may publish in the future.

Co-authorship network of co-authors of Joseph Eid

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Eid. A scholar is included among the top collaborators of Joseph Eid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Eid. Joseph Eid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Eid, Joseph, Ethan Ritz, F. Collado, et al.. (2024). Investigation of outcomes following transcatheter edge to edge repair of the mitral valve versus medical management alone in patients with cardiogenic shock and mitral regurgitation. SHILAP Revista de lepidopterología. 45. 100430–100430. 1 indexed citations
2.
Eid, Joseph, et al.. (2020). Supraventricular Tachycardia and Postural Orthostatic Tachycardia Syndrome Overlap: A Retrospective Study. Journal of Innovations in Cardiac Rhythm Management. 12(2). 4385–4389. 3 indexed citations
3.
Eid, Joseph, et al.. (2020). A single, shared origin for all three coronary arteries from the right coronary cusp: a case report. Journal of Medical Case Reports. 14(1). 94–94. 1 indexed citations
4.
Brescia, Alexander A., Tessa M.F. Watt, Joseph Eid, et al.. (2020). Rheumatic mitral valve repair or replacement in the valve-in-valve era. Journal of Thoracic and Cardiovascular Surgery. 163(2). 591–602.e1. 16 indexed citations
5.
Eid, Joseph, et al.. (2020). Gag Reflex-Mediated Restoration of Sinus Rhythm during TEE Probe Insertion for Atrial Fibrillation: A Word of Caution. SHILAP Revista de lepidopterología. 2020. 1–2. 4 indexed citations
6.
Siegel, David S., Meletios Α. Dimopoulos, Sundar Jagannath, et al.. (2016). VANTAGE 095: An International, Multicenter, Open-Label Study of Vorinostat (MK-0683) in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 16(6). 329–334.e1. 23 indexed citations
7.
Kirschbaum, Mark, Ivana Gojo, Stuart L. Goldberg, et al.. (2014). A phase 1 clinical trial of vorinostat in combination with decitabine in patients with acute myeloid leukaemia or myelodysplastic syndrome. British Journal of Haematology. 167(2). 185–193. 96 indexed citations
8.
Dimopoulos, Meletios Α., David S. Siegel, Sagar Lonial, et al.. (2013). Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study. The Lancet Oncology. 14(11). 1129–1140. 181 indexed citations
9.
Dimopoulos, Meletios Α., Sundar Jagannath, Sung‐Soo Yoon, et al.. (2011). Vantage 088: Vorinostat in Combination with Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma: Results of a Global, Randomized Phase 3 Trial. Blood. 118(21). 811–811. 32 indexed citations
10.
11.
Kurzrock, Razelle, Amita Patnaik, Joseph Aisner, et al.. (2010). A Phase I Study of Weekly R1507, A Human Monoclonal Antibody Insulin-like Growth Factor-I Receptor Antagonist, in Patients with Advanced Solid Tumors. Clinical Cancer Research. 16(8). 2458–2465. 158 indexed citations
12.
13.
14.
Österborg, Anders, Juan Luis Steegmann, Andrzej Hellmann, et al.. (2007). Phase II study of three dose levels of continuous erythropoietin receptor activator (C.E.R.A.) in anaemic patients with aggressive non‐Hodgkin’s lymphoma receiving combination chemotherapy. British Journal of Haematology. 136(5). 736–744. 12 indexed citations
15.
Huang, Yiwu, et al.. (2003). Hydroxyurea‐induced splenic regrowth in an adult patient with severe hemoglobin SC disease. American Journal of Hematology. 74(2). 125–126. 9 indexed citations
16.
Strair, Roger, Dale Schaar, Lauri Goodell, et al.. (2002). Administration of a phorbol ester to patients with hematological malignancies: preliminary results from a phase I clinical trial of 12-O-tetradecanoylphorbol-13-acetate.. PubMed. 8(8). 2512–8. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne-Marie O’Farrell Breakdown of academic impact, for papers by Steven M. Bair Breakdown of academic impact, for papers by Claire Bléchet Breakdown of academic impact, for papers by I Marschitz Breakdown of academic impact, for papers by Carmen Julia Tartari Breakdown of academic impact, for papers by Ayako Mitsuma Breakdown of academic impact, for papers by Petra Goldin-Lang Breakdown of academic impact, for papers by Paraskevi Kotsi Breakdown of academic impact, for papers by Ram Chillar Breakdown of academic impact, for papers by Emma Guagnellini
Rankless by CCL
2026